Cargando…

Comparison between Urine and Cervical High-Risk HPV Tests for Japanese Women with ASC-US

Most uterine cervical cancers are caused by the persistent infection of the high-risk human papillomavirus (hrHPV). Thus, the hrHPV-DNA test, which examines specimens from the cervix, is the standard screening method as well as cytology in western countries. Urine sampling for the hrHPV-DNA test wou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamazaki, Hiroyuki, Wada, Tsuneyuki, Asano, Hiroshi, Fujita, Hiromasa, Okamoto, Kazuhira, Watari, Hidemichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534778/ https://www.ncbi.nlm.nih.gov/pubmed/34679592 http://dx.doi.org/10.3390/diagnostics11101895

Ejemplares similares

Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese data
por: Aoki, Eiko Saitoh, et al.
Publicado: (2022)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Cervical Screening in North Sardinia (Italy): Genotype Distribution and Prevalence of HPV among Women with ASC-US Cytology
por: Muresu, Narcisa, et al.
Publicado: (2022)

Management of ASC-US/HPV positive post-menopausal woman
por: Bruno, Maria Teresa, et al.
Publicado: (2019)

Distribution of cervical lesions in high-risk HPV (hr-HPV) positive women with ASC-US: a retrospective single-center study in China
por: Wang, Zhiling, et al.
Publicado: (2020)

Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: The Korean HPV cohort
por: So, Kyeong A, et al.
Publicado: (2018)

Reduction in HPV16/18 prevalence among young women with high‐grade cervical lesions following the Japanese HPV vaccination program
por: Matsumoto, Koji, et al.
Publicado: (2019)

HPV-DNA testing for patients with ASC-US helps identify the women who have a high risk for precancerous cervical lesions
por: Moarcăs, M, et al.
Publicado: (2014)

Immunocytoexpression profile of ProExC in smears interpreted as ASC-US, ASC-H, and cervical intraepithelial lesion
por: Tosuner, Zeynep, et al.
Publicado: (2017)

The gray zone squamous lesions: ASC-US / ASC-H
por: Kattoor, Jayasree, et al.
Publicado: (2022)

Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification
por: Yamazaki, Hiroyuki, et al.
Publicado: (2022)

The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL
por: Possati-Resende, Júlio C., et al.
Publicado: (2015)

A prediction model of survival for patients with bone metastasis from uterine cervical cancer
por: Matsumiya, Hiroko, et al.
Publicado: (2016)

Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort
por: Endo, Daisuke, et al.
Publicado: (2015)

Chemotherapy and molecular targeting therapy for recurrent cervical cancer
por: Tsuda, Naotake, et al.
Publicado: (2016)

Concurrent chemoradiotherapy for cervical cancer: background including evidence-based data, pitfalls of the data, limitation of treatment in certain groups
por: Todo, Yukiharu, et al.
Publicado: (2016)

Does the ThinPrep Imaging System increase the detection of high-risk HPV-positive ASC-US and AGUS? The Women and Infants Hospital experience with over 200,000 cervical cytology cases
por: Quddus, M. Rudhul, et al.
Publicado: (2009)

Analysis of the related factors of atypical squamous cells of undetermined significance (ASC-US) in cervical cytology of post-menopausal women
por: Li, Bijun, et al.
Publicado: (2023)

Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women
por: Shiko, Yuki, et al.
Publicado: (2020)

Frequency of night shift and menstrual cycle characteristics in Japanese nurses working under two or three rotating shifts
por: Mayama, Michinori, et al.
Publicado: (2020)

Efficacy of urine loss ratio for prognosis of urinary continence after radical prostatectomy: A retrospective cohort study in a single Japanese institution
por: Watari, Shogo, et al.
Publicado: (2023)

Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing
por: Vorsters, Alex, et al.
Publicado: (2016)

HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations
por: Torres-Rojas, Francisco I., et al.
Publicado: (2021)

Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain
por: Ibáñez, Raquel, et al.
Publicado: (2012)

Successful Preventive Treatment of Oncogenic Transforming HPV Infections in Low-Grade Cytology (ASC-US/LSIL) Patients with an Adsorptive and Antioxidant Vaginal Gel
por: Major, Attila Louis, et al.
Publicado: (2023)

Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1
por: Einstein, Mark H., et al.
Publicado: (2023)

Nerve-sparing radical hysterectomy in the precision surgery for cervical cancer
por: Sakuragi, Noriaki, et al.
Publicado: (2020)

Urine HPV in the Context of Genital and Cervical Cancer Screening—An Update of Current Literature
por: Daponte, Alexandros, et al.
Publicado: (2021)

Value of CCNA1 Promoter Methylation in Triaging ASC-US Cytology
por: Oranratanaphan, Shina, et al.
Publicado: (2020)

Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay
por: Nilyanimit, Pornjarim, et al.
Publicado: (2017)

Urine collection in cervical cancer screening – analytical comparison of two HPV DNA assays
por: Tranberg, Mette, et al.
Publicado: (2020)

Status of the Current Treatment Options and Potential Future Targets in Uterine Leiomyosarcoma: A Review
por: Asano, Hiroshi, et al.
Publicado: (2022)

Risk factors for HPV infection and high-grade cervical disease in sexually active Japanese women
por: Yamaguchi, Manako, et al.
Publicado: (2021)

Can HPV Test on Random Urine Replace Self-HPV Test on Vaginal Self-Samples or Clinician-Collected Cervical Samples?
por: Shih, Yu-Hsiang, et al.
Publicado: (2023)

Risk of High-Grade Cervical Lesions in Atypical Squamous Cells of Undetermined Significance (ASC-US) Cytology: Comparison between HIV-Infected and HIV-Negative Women
por: Srisomboon, Santipap, et al.
Publicado: (2021)

Evaluation of p16/Ki-67 Dual Staining Compared with HPV Genotyping in Anal Cytology with Diagnosis of ASC-US for Detection of High-Grade Anal Intraepithelial Lesions
por: Pichon, Maxime, et al.
Publicado: (2019)

Analysis of HR-HPV Infection Concordance Rates in Cervical and Urine Specimens; Proposal of Additional Cervical Screening Process for Women Who Refuse Invasive Cervical Sampling
por: Kim, Dong Hyeok, et al.
Publicado: (2022)

Comparisons of high-risk cervical HPV infections in Caribbean and US populations
por: Ragin, Camille C, et al.
Publicado: (2009)

Koilocytes due to HPV in the urine sediment
por: Poloni, José Antonio Tesser, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dnd2hqi5aisj5cns4o6p8m0du0